Total Payments
$5,364
2024 Payments
$1,329
Companies
23
Transactions
267
Medicare Patients
1,885
Medicare Billing
$194,699
Payment Breakdown by Category
Food & Beverage$5,255 (98.0%)
Education$108.88 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,255 | 265 | 98.0% |
| Education | $108.88 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,332 | 74 | $0 (2024) |
| GENZYME CORPORATION | $892.22 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $565.97 | 30 | $0 (2024) |
| Optinose US, Inc. | $523.73 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $245.63 | 12 | $0 (2024) |
| Blueprint Medicines Corporation | $234.70 | 8 | $0 (2024) |
| Genentech USA, Inc. | $195.73 | 6 | $0 (2024) |
| CSL Behring | $164.82 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $163.56 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $163.34 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,329 | 55 | GENZYME CORPORATION ($406.23) |
| 2023 | $1,110 | 50 | GlaxoSmithKline, LLC. ($285.25) |
| 2022 | $831.08 | 48 | AstraZeneca Pharmaceuticals LP ($183.21) |
| 2021 | $970.75 | 47 | GlaxoSmithKline, LLC. ($303.02) |
| 2020 | $466.25 | 27 | GlaxoSmithKline, LLC. ($176.41) |
| 2019 | $341.95 | 18 | GlaxoSmithKline, LLC. ($147.34) |
| 2018 | $202.11 | 15 | GlaxoSmithKline, LLC. ($73.13) |
| 2017 | $112.29 | 7 | GlaxoSmithKline, LLC. ($32.98) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $103.21 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $113.74 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Immunology | ||||||
| 09/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/31/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 360 | 4,057 | $137,305 | $32,804 |
| 2022 | 11 | 406 | 5,442 | $174,361 | $46,178 |
| 2021 | 11 | 576 | 6,296 | $225,924 | $63,159 |
| 2020 | 12 | 543 | 6,071 | $210,239 | $52,558 |
Total Patients
1,885
Total Services
21,866
Medicare Billing
$194,699
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 63 | 1,705 | $57,315 | $15,840 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 51 | $14,022 | $4,278 | 30.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 21 | 1,481 | $25,598 | $4,169 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,941 | $2,762 | 34.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 57 | 299 | $14,948 | $2,082 | 13.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 12 | 212 | $4,345 | $1,187 | 27.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 28 | 41 | $4,325 | $726.94 | 16.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 36 | 53 | $2,169 | $662.49 | 30.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 19 | 20 | $3,235 | $548.40 | 17.0% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 21 | 25 | $884.00 | $283.92 | 32.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 50 | 147 | $2,523 | $264.12 | 10.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 77 | 2,581 | $85,173 | $26,927 | 31.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 24 | 1,800 | $30,600 | $4,987 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 49 | $13,230 | $4,024 | 30.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 68 | 401 | $19,649 | $2,731 | 13.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,920 | $2,690 | 34.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 17 | 305 | $6,100 | $1,814 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $3,330 | $1,018 | 30.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 33 | 45 | $4,095 | $797.04 | 19.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 37 | 51 | $1,989 | $626.92 | 31.5% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 23 | 28 | $980.00 | $319.38 | 32.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 53 | 140 | $1,295 | $244.96 | 18.9% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 81 | 2,860 | $94,380 | $31,552 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 145 | $39,150 | $12,642 | 32.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 31 | 1,960 | $33,372 | $5,620 | 16.8% |
About Dr. Marshall Wise, MD
Dr. Marshall Wise, MD is a Allergy & Immunology healthcare provider based in Georgetown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427105394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Wise, MD has received a total of $5,364 in payments from pharmaceutical and medical device companies, with $1,329 received in 2024. These payments were reported across 267 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,255).
As a Medicare-enrolled provider, Wise has provided services to 1,885 Medicare beneficiaries, totaling 21,866 services with total Medicare billing of $194,699. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy & Immunology
- Location Georgetown, KY
- Active Since 01/04/2007
- Last Updated 07/11/2025
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1427105394
Products in Payments
- DUPIXENT (Biological) $1,125
- NUCALA (Biological) $1,062
- Xhance (Drug) $523.73
- TEZSPIRE (Biological) $475.73
- AYVAKIT (Drug) $234.70
- TRELEGY ELLIPTA (Drug) $201.04
- Xolair (Biological) $195.73
- XOLAIR (Drug) $191.89
- SPIRIVA RESPIMAT (Drug) $134.53
- Haegarda (Biological) $99.66
- FASENRA (Drug) $91.35
- AirDuo Digihaler (Drug) $81.58
- Prolastin-C Liquid (Biological) $81.21
- EUCRISA (Drug) $70.79
- Orladeyo (Drug) $70.20
- ORLADEYO (Drug) $70.03
- Hizentra (Biological) $65.16
- XOLAIR (Biological) $53.74
- FASENRA (Biological) $52.60
- CUVITRU (Biological) $44.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.